Abstract
Orlistat is an orally administered anti-obesity drug that has shown significant antitumor activity in a variety of tumor cells. To identify the proteins involved in its antitumor activity, we employed a proteomic approach to reveal protein expression changes in the human ovarian cancer cell line SKOV3, following Orlistat treatment. Protein expression profiles were analyzed by 2-dimensional polyacrylamide gel electrophoresis (2-DE) and protein identification was performed on a MALDI-Q-TOF MS/MS instrument. More than 110 differentially expressed proteins were visualized by 2-DE and Coomassie brilliant blue staining. Furthermore, 71 proteins differentially expressed proteins were positively identified via mass spectrometry (MS)/MS analysis. In particular, PKM1/2, a key enzyme involved in tumorigenesis, was found to be significantly downregulated in SKOV3 cells following treatment with Orlistat. Moreover, PKM1/2 was proved to be downregulated in SKOV3 cells by western blot analysis after treatment with Orlistat. Taken together, using proteomic tools, we identified several differentially expressed proteins that underwent Orlistat-induced apoptosis, particularly PKM2. These changes confirmed our hypothesis that Orlistat is a potentia...Continue Reading
References
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·F P KuhajdaG R Pasternack
Feb 1, 1996·Cancer·P L Alo'U Di Tondo
Jan 1, 1997·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·E S PizerF P Kuhajda
Jun 1, 1997·Human Pathology·T S GanslerR A Hennigar
May 17, 2000·The Journal of Experimental Medicine·J JankeS Scherneck
Oct 3, 2000·Human Pathology·C J PiyathilakeW E Grizzle
Oct 18, 2000·Oncology Reports·P L AlòU Di Tondo
Jun 1, 2001·British Journal of Cancer·J H BullL Paskins
Jul 13, 2001·American Journal of Clinical Pathology·P L AlòE S Pizer
Mar 21, 2002·Histopathology·T KusakabeT Suzuki
Sep 27, 2002·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·T NemotoM Gotoh
Apr 20, 2004·Oncogene·Michael J Clemens
May 13, 2004·The Journal of Biological Chemistry·Lynn M KnowlesJeffrey W Smith
Feb 25, 2005·Lipids·Subrahmanyam S Chirala, Salih J Wakil
Mar 1, 2005·Experimental Biology and Medicine·Javier A MenendezRuth Lupu
May 24, 2005·Seminars in Cancer Biology·Sybille MazurekErich Eigenbrodt
Jul 6, 2005·Biochemistry·Jill D DombrauckasAndrew D Mesecar
Mar 3, 2006·Molecular and Cellular Biochemistry·Leslie C Costello, Renty B Franklin
May 3, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mari RakiAkseli Hemminki
Oct 20, 2006·Proteomics·Nan WuXi-Liang Zha
Feb 20, 2007·Cancer Research·Attila StetákAxel Ullrich
Mar 22, 2007·The Journal of Biological Chemistry·Andrzej WitkowskiStuart Smith
Jul 10, 2007·Nature Structural & Molecular Biology·Charles W PembleW Todd Lowther
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Mar 14, 2008·Nature·Heather R ChristofkLewis C Cantley
Apr 22, 2008·International Journal of Cancer. Journal International Du Cancer·Gilles A SpodenWerner Zwerschke
May 21, 2008·Proteomics·Aiping TongYu-quan Wei
Aug 30, 2008·Molecular & Cellular Proteomics : MCP·Rui LiuCanhua Huang
Jun 12, 2010·Expert Review of Proteomics·Rui LiuCanhua Huang
Citations
May 29, 2014·PloS One·Chen YanHan Sheng
Apr 5, 2014·Journal of Pharmaceutical and Biomedical Analysis·Miguel Angel Merlos RodrigoRene Kizek
Mar 24, 2018·International Journal of Cancer. Journal International Du Cancer·Efthymia PapaevangelouYuen-Li Chung
May 4, 2018·Expert Opinion on Investigational Drugs·Alejandro Schcolnik-CabreraAlfonso Dueñas-González
Nov 30, 2019·Journal of Chemotherapy·Giorgia CioccoloniOrnella Franzese
Jul 6, 2018·Archives of Gynecology and Obstetrics·Hongling PengXia Zhao